-
1
-
-
0028295289
-
IgE determination in neonates is not suitable for general screening
-
Kjellman N-IM. IgE determination in neonates is not suitable for general screening. Ped Allergy Immunol 1994; 5:1-4.
-
(1994)
Ped Allergy Immunol
, vol.5
, pp. 1-4
-
-
Kjellman, N.-I.M.1
-
2
-
-
0029007501
-
Compliance in asthma: A European perspective
-
Cochrane GM. Compliance in asthma: a European perspective. Eur Resp Rev 1995; 5:116-9.
-
(1995)
Eur Resp Rev
, vol.5
, pp. 116-119
-
-
Cochrane, G.M.1
-
3
-
-
0029787901
-
Important issues in childhood asthma
-
Pederson S. Important issues in childhood asthma. Eur Resp Rev 1996; 6:192-6.
-
(1996)
Eur Resp Rev
, vol.6
, pp. 192-196
-
-
Pederson, S.1
-
4
-
-
0343177506
-
Risk factors in the development of allergy
-
Schatz M, Zeiger R, Claman H.eds. Asthma and Immunological Diseases in Pregnancy and Early Infancy. Lenfant C, eds. New York: Marcel Dekker
-
Björkstén B, Kjellman M-IM. Risk factors in the development of allergy. In: Schatz M, Zeiger R, Claman H.eds. Asthma and Immunological Diseases in Pregnancy and Early Infancy. (Lenfant C, eds. Lung Biology in Health and Disease, Vol 110) New York: Marcel Dekker, 1997: 677-702.
-
(1997)
Lung Biology in Health and Disease
, vol.110
, pp. 677-702
-
-
Björkstén, B.1
Kjellman, M.-I.M.2
-
5
-
-
0005065215
-
Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomized, placebo-controlled trial: First results of ETAC
-
ETAC Study Group. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomized, placebo-controlled trial: first results of ETAC. Ped Allergy Immunol 1998; 9:116-24.
-
(1998)
Ped Allergy Immunol
, vol.9
, pp. 116-124
-
-
-
6
-
-
0026578963
-
Allergy prevention by maternal elimination diet during late pregnancy - A 5-year follow-up of a randomized study
-
Fäith-Magnusson K, Kjellman N-IM. Allergy prevention by maternal elimination diet during late pregnancy - a 5-year follow-up of a randomized study. J Allergy Clin Immunol 1992; 89:709-13.
-
(1992)
J Allergy Clin Immunol
, vol.89
, pp. 709-713
-
-
Fäith-Magnusson, K.1
Kjellman, N.-I.M.2
-
7
-
-
0030678565
-
Capacity of specific immunotherapy in prevention of allergic asthma in children: The preventive allergy treatment study (PAT)
-
Valovirta E. Capacity of specific immunotherapy in prevention of allergic asthma in children: the preventive allergy treatment study (PAT). J Invest Allergol Clin Immunol 1997; 7:369-70.
-
(1997)
J Invest Allergol Clin Immunol
, vol.7
, pp. 369-370
-
-
Valovirta, E.1
-
8
-
-
1842370350
-
Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and corticosteriods establishing therapy (FACET) International Study Group
-
Pauwels RA, Lofdahl CG, Postma DS et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and corticosteriods Establishing Therapy (FACET) International Study Group. New Engl J Med 1997; 337:1405-11.
-
(1997)
New Engl J Med
, vol.337
, pp. 1405-1411
-
-
Pauwels, R.A.1
Lofdahl, C.G.2
Postma, D.S.3
-
9
-
-
0028264310
-
Added salmeterol vs higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
-
Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol vs higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994; 344:219-24.
-
(1994)
Lancet
, vol.344
, pp. 219-224
-
-
Greening, A.P.1
Ind, P.W.2
Northfield, M.3
Shaw, G.4
|